BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12644017)

  • 1. Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis: a sequential study in 42 patients.
    Hernández-Boluda JC; Cervantes F; Colomer D; Vela MC; Costa D; Paz MF; Esteller M; Montserrat E
    Exp Hematol; 2003 Mar; 31(3):204-10. PubMed ID: 12644017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia.
    Sill H; Goldman JM; Cross NC
    Blood; 1995 Apr; 85(8):2013-6. PubMed ID: 7718873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between blast crisis of chronic myeloid leukemias and abnormality of p16 and calcitonin genes].
    Xu D; Hong W; Wang S
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):151-3. PubMed ID: 11776646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic and genotypic characteristics of chronic myelogenous leukemia in blast crisis.
    Yen CC; Liu JH; Wang WS; Fan FS; Chiou TJ; Tai CJ; Yang MH; Chao TC; Hsiao LT; Chen PM
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Nov; 63(11):785-91. PubMed ID: 11155753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletions of immunoglobulin heavy chain and T cell receptor gene regions are uniquely associated with lymphoid blast transformation of chronic myeloid leukemia.
    Nacheva EP; Brazma D; Virgili A; Howard-Reeves J; Chanalaris A; Gancheva K; Apostolova M; Valgañon M; Mazzullo H; Grace C
    BMC Genomics; 2010 Jan; 11():41. PubMed ID: 20082691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia.
    Serra A; Gottardi E; Della Ragione F; Saglio G; Iolascon A
    Br J Haematol; 1995 Nov; 91(3):625-9. PubMed ID: 8555065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Cervantes F; Sanchez J; Garate L; Barrios M; Castillejo JA; Navarro G; Colomer D; Prosper F; Heiniger A; Torres A
    Oncogene; 2005 Nov; 24(48):7213-23. PubMed ID: 16170379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia.
    Mori N; Morosetti R; Spira S; Lee S; Ben-Yehuda D; Schiller G; Landolfi R; Mizoguchi H; Koeffler HP
    Blood; 1998 Nov; 92(9):3405-9. PubMed ID: 9787180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia.
    Ch'ang HJ; Tien HF; Wang CH; Chuang SM; Chen YC; Shen MC; Lin DT; Lin KH
    Cancer Genet Cytogenet; 1993 Nov; 71(1):87-93. PubMed ID: 8275458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent p53 gene mutations in blast crisis of chronic myelogenous leukemia, especially in myeloid crisis harboring loss of a chromosome 17p.
    Nakai H; Misawa S; Toguchida J; Yandell DW; Ishizaki K
    Cancer Res; 1992 Dec; 52(23):6588-93. PubMed ID: 1423304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib mesylate as first-line therapy in patients with chronic myeloid leukemia in accelerated phase and blast phase: a retrospective analysis.
    Thota NK; Gundeti S; Linga VG; Coca P; Tara RP;
    Indian J Cancer; 2014; 51(1):5-9. PubMed ID: 24947087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphenotypic blast crisis of chronic myelogenous leukemia: abnormalities of p53 and retinoblastoma genes.
    Ishikura H; Yufu Y; Yamashita S; Abe Y; Okamura T; Motomura S; Nishimura J; Nawata H
    Leuk Lymphoma; 1997 May; 25(5-6):573-8. PubMed ID: 9250829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia.
    Hernández JM; González-Sarmiento R; Martin C; González M; Sánchez I; Corral J; Orfao A; Cañizo MC; San Miguel JF; López-Borrasca A
    Br J Haematol; 1991 Nov; 79(3):408-14. PubMed ID: 1751368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
    Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C
    Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques.
    Neubauer A; He M; Schmidt CA; Huhn D; Liu ET
    Leukemia; 1993 Apr; 7(4):593-600. PubMed ID: 8464238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia.
    Asimakopoulos FA; Shteper PJ; Krichevsky S; Fibach E; Polliack A; Rachmilewitz E; Ben-Neriah Y; Ben-Yehuda D
    Blood; 1999 Oct; 94(7):2452-60. PubMed ID: 10498618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of p16 gene in hematological malignancies.
    Chen W; Zhu J; Liu J; Tan S
    Chin Med J (Engl); 1998 Nov; 111(11):1028-30. PubMed ID: 11189209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.
    Xu L; Lu Y; Lai J; Yu W; Zhang Y; Jin Z; Xu Y; Chen J; Zha X; Chen S; Yang L; Li Y
    Sci China Life Sci; 2015 Dec; 58(12):1276-81. PubMed ID: 26423566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.